Solventum Corp (SOLV): SOLV 3Q24 Results by Business Segment...

Next 10 Prev Next

Send PM Follow Ignore

Followers	843
Posts	123050
Boards Moderated	9
Alias Born	09/05/2002

DewDiligence

Re: DewDiligence post# 22

Thursday, 11/07/2024 7:07:40 PM

Thursday, November 07, 2024 7:07:40 PM

SOLV 3Q24 Results by Business Segment

%Corp YoY Growth
Segment Sales Organic Sales†
Medical/surgical* 57% +1%
Dental 15% -4%
Health-info systems 16% +2%
Purification/filtration 11% 0%

†Excludes acquisitions, divestitures, and currency.

*Includes components for other companies’ medical devices.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Keep Last Read

Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent SOLV News

Form SD - Specialized disclosure report • Edgar (US Regulatory) • 05/29/2026 08:14:39 PM
Form 8-K - Current report • Edgar (US Regulatory) • 05/27/2026 08:23:24 PM
Solventum to Participate in the 2026 Jefferies Healthcare Conference • PR Newswire (US) • 05/27/2026 08:05:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 05/20/2026 08:14:28 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/15/2026 08:10:35 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/15/2026 08:09:53 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/15/2026 08:07:54 PM
Solventum to Participate in the 2026 BofA Securities Health Care Conference • PR Newswire (US) • 05/07/2026 08:05:00 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/05/2026 09:29:15 PM
Form 8-K - Current report • Edgar (US Regulatory) • 05/05/2026 08:08:36 PM
Solventum Reports First Quarter 2026 Financial Results • PR Newswire (US) • 05/05/2026 08:05:00 PM
Trian Calls on Solventum's Board to Create Value; Publishes Open Letter and Slide Deck • GlobeNewswire Inc. • 04/30/2026 05:05:00 PM
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 04/30/2026 04:59:19 PM
Solventum to Report First Quarter Fiscal 2026 Earnings on May 5, 2026 • PR Newswire (US) • 04/14/2026 08:05:00 PM
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 03/27/2026 08:17:58 PM
Form 8-K - Current report • Edgar (US Regulatory) • 03/24/2026 08:35:11 PM
Solventum to Participate in the 2026 KeyBanc Healthcare Forum • PR Newswire (US) • 03/11/2026 08:05:00 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/09/2026 11:49:55 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/09/2026 11:49:34 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/09/2026 11:47:48 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/26/2026 09:08:05 PM
Solventum Reports Fourth Quarter 2025 Financial Results and Introduces 2026 Full-Year Guidance • PR Newswire (US) • 02/26/2026 09:05:00 PM
Solventum to Report Fourth Quarter and Full Year Fiscal 2025 Earnings on February 26, 2026 • PR Newswire (US) • 02/03/2026 09:05:00 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/03/2026 03:01:46 PM
Solventum Completes Acquisition of Acera Surgical • PR Newswire (US) • 12/23/2025 09:05:00 PM

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

Detailed Quote

Recent SOLV News

More SOLV News

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

Recent SOLV News

Go Ad-Free